PCV20 A COST EFFECTIVENESS ANALYSIS OF SPIRONOLACTONE IN THE MANAGEMENT OF PATIENTS WITH SEVERE CHRONIC HEART FAILURE (CHF) IN THE IRISH HEALTHCARE SETTING
Nov 1, 2002, 00:00
10.1016/S1098-3015(10)61291-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)61291-0/fulltext
Title :
PCV20 A COST EFFECTIVENESS ANALYSIS OF SPIRONOLACTONE IN THE MANAGEMENT OF PATIENTS WITH SEVERE CHRONIC HEART FAILURE (CHF) IN THE IRISH HEALTHCARE SETTING
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61291-0&doi=10.1016/S1098-3015(10)61291-0
First page :
Section Title :
Open access? :
No
Section Order :
99